<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    AVROBIO, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About AVROBIO, Inc.

    AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage company developing disruptive therapies that have the potential to transform patients’ lives in a single dose. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $440,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Geoff MacKay
    • FOUNDED
      2015
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Histogenics Corporation

    Histogenics Corporation

    Histogenics historically focused on the development of restorative cell therapies,...

    Histogenics historically focused on the develop...

    Filing Type:    PU
    Surgery Partners, Inc.

    Surgery Partners, Inc.

    Headquartered in Nashville, Tennessee, Surgery Partners is a leading healthcare se...

    Headquartered in Nashville, Tennessee, Surgery ...

    Filing Type:    PU
    ENDRA Life Sciences Inc.

    ENDRA Life Sciences Inc.

    ENDRA Life Sciences' mission is to bring new capabilities to ultrasound and broade...

    ENDRA Life Sciences' mission is to bring new ca...

    Filing Type:    PU
    MiMedx Group, Inc.

    MiMedx Group, Inc.

    MiMedxŽ is a biopharmaceutical company developing, manufacturing and marketing reg...

    MiMedxŽ is a biopharmaceutical company developi...

    Filing Type:    PU
    Kazia Therapeutics Limited

    Kazia Therapeutics Limited

    Kazia Therapeutics is an oncology-focused biotechnology company, developing innova...

    Kazia Therapeutics is an oncology-focused biote...

    Filing Type:    PU
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    Mustang Bio, Inc.

    Mustang Bio, Inc.

    Mustang Bio, Inc. (“Mustang”), a Fortress Biotech Company, is a clinical-stage...

    Mustang Bio, Inc. (“Mustang”), a Fortress B...

    Filing Type:    PU
    REGENXBIO Inc.

    REGENXBIO Inc.

    REGENXBIO is a leading biotechnology company focused on the development, commercia...

    REGENXBIO is a leading biotechnology company fo...

    Filing Type:    PU
    Tocagen Inc.

    Tocagen Inc.

    Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...

    Tocagen is a clinical-stage, cancer-selective g...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.